MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)

Phase 3
Terminated
Conditions
Respiratory Distress Syndrome, Adult
Interventions
Behavioral: Minimal (Trophic) Feeding
Behavioral: Full Feeding
Dietary Supplement: Placebo
Dietary Supplement: Omega-3 Fatty Acids and Antioxidant Supplements
First Posted Date
2008-02-06
Last Posted Date
2016-04-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
272
Registration Number
NCT00609180
Locations
🇺🇸

Wake Forest University Baptist Medical Center, Winston Salem, North Carolina, United States

🇺🇸

University of Virginia Medical Center, Charlottesville, Virginia, United States

🇺🇸

Baystate Medical Center, Springfield, Massachusetts, United States

and more 38 locations

Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma

Phase 2
Withdrawn
Conditions
Asthma
Airway Inflammation
Airflow Obstruction
Airway Hyperactivity
First Posted Date
2008-01-30
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00604578
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

🇺🇸

Fairfax Hospital, Falls Church, Virginia, United States

Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome

Phase 2
Completed
Conditions
Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)
Severe Aplastic Anemia (SAA)
Interventions
Biological: Umbilical Cord Blood
First Posted Date
2008-01-30
Last Posted Date
2022-01-05
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
31
Registration Number
NCT00604201
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Pilot Study to Assess the Proteome in Human Atrial Tissue

Completed
Conditions
Diabetes
Cardiomyopathy
First Posted Date
2008-01-11
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
600
Registration Number
NCT00591903
Locations
🇺🇸

Suburban Hospital, Bethesda, Maryland, United States

Relation of White Blood Cell Function to Diabetes

Completed
Conditions
Diabetes
First Posted Date
2007-12-10
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
100
Registration Number
NCT00570154
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Evaluating Electrocardiogram (ECG) Abnormalities From Young Adulthood Through Middle Age

Completed
Conditions
Cardiovascular Diseases
First Posted Date
2007-11-12
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
5115
Registration Number
NCT00556751
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women

Completed
Conditions
Tuberous Sclerosis
Lymphangioleiomyomas
Lymphangioleiomyomatosis
First Posted Date
2007-11-02
Last Posted Date
2019-03-06
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
35
Registration Number
NCT00552955
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)

Phase 3
Completed
Conditions
Diabetic Retinopathy
Interventions
Drug: Intensive BP treatment
Drug: Standard BP control
Drug: Standard glycemia control
Drug: Placebo
First Posted Date
2007-10-10
Last Posted Date
2018-07-24
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
3472
Registration Number
NCT00542178
Locations
🇺🇸

Veterans Affairs, Memphis, Tennessee, United States

🇺🇸

Columbia University, New York, New York, United States

🇺🇸

The Berman Center for Clinical Research, Minneapolis, Minnesota, United States

and more 4 locations

Safety of ON 01910.Na in Patients With Myelodysplasia

Phase 1
Completed
Conditions
Myelodysplastic Syndrome (MDS)
First Posted Date
2007-09-21
Last Posted Date
2019-12-17
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
14
Registration Number
NCT00533416
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Establishing a Database of People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Data Project [C-Data])

Terminated
Conditions
Anemia, Sickle Cell
First Posted Date
2007-09-14
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
3640
Registration Number
NCT00529061
Locations
🇺🇸

Children's Hospital of Oakland, Oakland, California, United States

🇺🇸

Kosair Children's Hospital, Louisville, Kentucky, United States

🇺🇸

Brigham & Women's Hospital, Boston, Massachusetts, United States

and more 16 locations
© Copyright 2025. All Rights Reserved by MedPath